LOGIN  |  REGISTER
Assertio
Compass Therapeutics

Tenet Healthcare to Participate in 44th Annual Goldman Sachs Global Healthcare Conference

May 31, 2023 | Last Trade: US$98.26 0.40 0.41

DALLAS / May 31, 2023 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the 44th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 13, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time).

A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at https://investor.tenethealth.com/. The replay will be available for 30 days.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 465 ambulatory surgery centers and surgical hospitals. We also operate 61 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

Assertio

Stock Quote

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB